Product ID: SQMIG35D2037
Global Virtual Clinical Trials Market Size, Share, Growth Analysis, By Indication(Oncology, Cardiovascular), By Study Design(Interventional, Observational) - Industry Forecast 2024-2031
Report ID:
SQMIG35D2037 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
63 |
Figures:
75
Global Virtual Clinical Trials Market Regional Insights
On the basis of region, global virtual clinical trials market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the global virtual clinical trials market. This is due to increasing R&D in the region, increased adoption of new technologies in clinical research, and government support. Also, market players are using digital technology to meet the needs of consumers. For example, Parexel conducted more than 100 decentralized tests with hybrid and virtual techniques. Covance also operates about 1,900 LabCorp Patient Service Centres across the United States, bringing testing to patients.
Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the increasing availability of a large patient, easy recruitment of candidates, and enhanced access to digital technology in the region. Also, the outbreak of coronavirus is expected to boost the adoption of telemedicine, thus boosting the market in the region. Japan was the largest market in the Asia Pacific due to high healthcare and R&D expenditures and growing demand for virtual clinical trials in the market.
Global Virtual Clinical Trials Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
